AAAAAA

   
Results: 1-11 |
Results: 11

Authors: MAUSKOPF J LACEY L KEMPEL A SIMPSON K
Citation: J. Mauskopf et al., THE COST-EFFECTIVENESS OF TREATMENT WITH LAMIVUDINE AND ZIDOVUDINE COMPARED WITH ZIDOVUDINE ALONE - A COMPARISON OF MARKOV MODEL AND TRIAL DATA ESTIMATES, American journal of managed care, 4(7), 1998, pp. 1004-1012

Authors: MAUSKOPF J SCHULMAN K BELL L GLICK H
Citation: J. Mauskopf et al., A STRATEGY FOR COLLECTING PHARMACOECONOMIC DATA DURING PHASE II III CLINICAL-TRIALS/, PharmacoEconomics, 9(3), 1996, pp. 264-277

Authors: DOYLE JJ CASCIANO JP ARIKIAN SR MAUSKOPF J PAUL JE
Citation: Jj. Doyle et al., FULL-COST DETERMINATION OF DIFFERENT LEVELS OF CARE IN THE INTENSIVE-CARE UNIT - AN ACTIVITY-BASED COSTING APPROACH, PharmacoEconomics, 10(4), 1996, pp. 395-408

Authors: SCHULMAN KA BUXTON M GLICK H SCULPHER M GUZMAN G KONG J BACKHOUSE M MAUSKOPF J BELL L EISENBERG JM CALIFF RM MCKENNA WJ HARRELL FE URETSKY BF ADAMS KF SWEDBERG KB GHEORGHIADE M ZANNAD F HANDBERG E DARIUS H SOLERSOLER J WHEELER WS ARMSTRONG PW PATTERSON H MURALI S BUTMAN S KIRLIN PC MILLER LW JAFRI S RICH S COSTANZONORDIN MR MCGOON M HOSENPUD JD RATKOVEC R BRUNDAGE B PRITZKER M BOURGE R REEVES W FORGOSH L VENTURA H YOUNG JB MANCINI D MILLS RM LIMACHER MC LEE F REVKIN J KALBFLEISCH JM FISHBEIN D PRESSLER M HAEUSSLEIN E KARLSBERG RP OCONNELL J LEJEMTEL TH THOMAS HM SMITH WB MCIVOR M CINTRON GB HAGER WD MESSINEO FC DOUGHERTY JE HASSAPOYANNES C HOOD W MCGREW F SANFORD CF OCONNER CM HOBBS RE YARDLEY D KAY R MINOTTI J EASTBURN TE LINDENFELD J LITMAN G WICKEMEYER W HORTON S GILBERT EM EICHORN E RIBNER HS CORDER C PHILBIN E NOCERO M ELKAYAM U JESSUP M CRAWFORD M CARSON P REDDY HK KLAPHOLZ M HEYWOOD JT SALINGER M KARLSBERG R BUSH D HUNTER C WOHNS D EISENBERG P WINSTON S BUTCHER C MASSIN E WYNNE J TONKON M SPACCAVENTO L DIVER D GHALI J HUTCHINS S ANAND I BEANLANDS D KOSTUK W PFLUGFELDER P LANGLEBEN D LATOUR P MIZGALA H RICCI D MANYARI D DARGIE HJ DAVIDSON C SWANTON H HUBNER PJB OAKLEY D BROOKS N JENNINGS K GREENBAUM RA PENNY WJ NICHOLLS P WALSH M SUGRUE D FENNELL W HORGAN JH JONDEAU G CASTAIGNE A LEMAREC H WALGER P PARK JW DEBERRAZUETA JR MOL MG SANCHEZ MAG CAPONNETTO S MAGNANI B GALIE N DEVITA C MASERI A BAGGER JP REMES J WALDENSTROM A SCHAUFELBERGER M DIENSTI F SIMOONS ML KLEIN W PACHER R KEOGH A HARLEY A
Citation: Ka. Schulman et al., RESULTS OF THE ECONOMIC-EVALUATION OF THE FIRST STUDY - A MULTINATIONAL PROSPECTIVE ECONOMIC-EVALUATION, International journal of technology assessment in health care, 12(4), 1996, pp. 698-713

Authors: MAUSKOPF J MARKOWITZ M HALPERN MT MURRAY M
Citation: J. Mauskopf et al., COST-EFFECTIVENESS MODEL FOR ESTIMATING THE VALUE OF LAMOTRIGINE (LAMICTAL) - A NEW DRUG FOR EPILEPSY TREATMENT, Neurology, 46(2), 1996, pp. 4132-4132

Authors: MAUSKOPF J
Citation: J. Mauskopf, INDUSTRY RESPONSIBILITY IN INTERACTIVE COMPUTER MODELING, Medical care, 34(12), 1996, pp. 165-172

Authors: CLEMENS K TOWNSEND R LUSCOMBE F MAUSKOPF J OSTERHAUS J BOBULA J
Citation: K. Clemens et al., METHODOLOGICAL AND CONDUCT PRINCIPLES FOR PHARMACOECONOMIC RESEARCH, PharmacoEconomics, 8(2), 1995, pp. 169-174

Authors: MAUSKOPF J AUSTIN R DIX L BERZON R
Citation: J. Mauskopf et al., THE NOTTINGHAM HEALTH PROFILE AS A MEASURE OF QUALITY-OF-LIFE IN ZOSTER PATIENTS - CONVERGENT AND DISCRIMINANT VALIDITY, Quality of life research, 3(6), 1994, pp. 431-435

Authors: BERZON R MAUSKOPF J SIMEON G
Citation: R. Berzon et al., QUALITY-OF-LIFE MEASUREMENT FOR DECISIONS ABOUT THE USE OF NEW THERAPEUTIC DRUGS - A TALE OF 2 NEEDS, Quality of life research, 3(1), 1994, pp. 46-46

Authors: MAUSKOPF J AUSTIN R DIX L BERZON R
Citation: J. Mauskopf et al., THE VALUE OF GENERIC MEASURES OF QUALITY-OF-LIFE, Quality of life research, 3(1), 1994, pp. 48-49

Authors: MAUSKOPF J TURNER BJ MARKSON LE HOUCHENS RL FANNING TR MCKEE L
Citation: J. Mauskopf et al., PATTERNS OF AMBULATORY CARE FOR AIDS PATIENTS, AND ASSOCIATION WITH EMERGENCY ROOM USE, Health services research, 29(4), 1994, pp. 489-510
Risultati: 1-11 |